Volume 11, Number 5—May 2005
Dispatch
Human T-cell Leukemia Virus Type 1 Molecular Variants, Vanuatu, Melanesia
Olivier Cassar*†, Corinne Capuano‡, Laurent Meertens†, Eliane Chungue*, and Antoine Gessain†
Table 1
Human T-cell leukemia virus type 1 (HTLV-1) antibody titers and molecular screening results for HTLV-1–seropositive women from Ambae Island, Vanuatu Archipelago*
| Virus strain | Age (y) | PA titers | IFA titers |
WB pattern | PCR |
|||
|---|---|---|---|---|---|---|---|---|
| MT 2 | C 19 | 3´ LTR | 5´ LTR | env | ||||
| VAN 54 | 45 | 1/2,048 | 1/320 | 1/80 | HTLV-I | + | + | + |
| VAN 136 | 36 | 1/8,192 | 1/1,280 | 1/320 | HTLV-I | + | + | + |
| VAN 251 | 42 | 1/1,024 | 1/40 | <1/20 | HTLV-I | + | + | + |
| VAN 335 | 42 | 1/4,096 | 1/1,280 | 1/160 | HTLV-I | + | + | + |
| DH1SIL2 (sister-in-law of VAN 335) | 56 | 1/8,192 | 1/2,560 | 1/320 | HTLV-I | NA | NA | NA |
| AWM (mother of VAN 54) | 63 | 1/1,024 | 1/160 | 1/40 | HTLV-I | NA | NA | NA |
*PA, particle agglutination; IFA, immunofluorescence assay; WB, Western blot; PCR, polymerase chain reaction; LTR, long terminal repeat; NA, DNA not available.
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.